Detalles de la búsqueda
1.
Safety and Effectiveness of Adalimumab in Patients With Polyarticular Course of Juvenile Idiopathic Arthritis: STRIVE Registry Seven-Year Interim Results.
Arthritis Care Res (Hoboken);
72(10): 1420-1430, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31421019
2.
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy.
Arthritis Rheumatol;
71(3): 451-459, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30225949
3.
A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis.
Pediatr Rheumatol Online J;
16(1): 41, 2018 Jun 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-29941047
4.
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease.
Arthritis Rheumatol;
70(9): 1508-1518, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29604189
5.
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies.
J Clin Invest;
128(7): 3041-3052, 2018 07 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29649002
6.
Reintroduction of etanercept during treatment of cutaneous Mycobacterium marinum infection in a patient with ankylosing spondylitis.
Arthritis Rheum;
61(5): 583-6, 2009 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19405014
Resultados
1 -
6
de 6
1
Próxima >
>>